S

Sandoz

Leader in generic and biosimilar medicines

Director – Policy Analytics

Regulatory Compliance & EthicsUpdated on Nov 12
Full-timePrinceton, NJ, USA

About the Job

Requirements

  • A bachelor's degree in finance, economics, public policy, healthcare administration, pharmacy, business, or a related field is required.
  • At least 15 years of progressive experience in pharmaceutical market access, government programs, healthcare policy, revenue management, government pricing, reimbursement, or compliance is required.
  • At least 5 years of leadership experience is required.
  • Deep understanding of the 340B Drug Pricing Program, Medicaid Drug Rebate Program, government pricing, gross-to-net processes, market access contracting, and healthcare policy and regulatory frameworks is required.
  • Experience working with cross-functional executive leadership teams is required.
  • Experience leading large-scale strategic initiatives and policy assessments is required.

Responsibilities

  • Develop and evaluate policy positions aligned with enterprise strategy, including market access, reimbursement, and regulatory frameworks.
  • Monitor and assess changes in the healthcare, insurance, and reimbursement landscape, including legislative and regulatory developments.
  • Analyze the business and patient impact of proposed legislation, regulations, and industry initiatives.
  • Report findings to senior leadership and drive decision-making on access and policy priorities.
  • Assess federal and state legislative, regulatory, and reimbursement changes affecting commercial, Medicaid, Medicare, and 340B programs.
  • Lead policy impact assessments and scenario modeling for proposed healthcare reforms.
  • Translate policy developments into actionable business recommendations.
  • Provide executive summaries and strategic insights to Finance, Market Access, and Commercial leaders.
  • Support long-term forecasting and risk management related to reimbursement and access policy shifts.
  • Quantify financial exposure associated with duplicate discounts, diversion, contract pharmacy utilization, and policy changes.
  • Lead analyses of rebate, chargeback, government pricing, and gross-to-net impacts.
  • Develop monitoring processes to identify emerging risks and revenue leakage opportunities.
  • Partner with Finance and Revenue Management teams on valuation of 340B strategies and initiatives.
  • Establish performance metrics and reporting dashboards.
  • Oversee assessment of potential diversion and duplicate discount scenarios.
  • Lead development and execution of manufacturer audit readiness programs.
  • Coordinate investigations involving covered entities and contract pharmacies.
  • Ensure adherence to HRSA requirements and industry best practices.
  • Partner with Legal and Compliance to manage regulatory inquiries and enforcement risks.
  • Drive implementation and optimization of 340B analytical solutions and platforms.
  • Partner with IT and data teams to strengthen monitoring capabilities.
  • Develop advanced analytics and reporting to identify trends, anomalies, and compliance risks.
  • Leverage data-driven insights to support policy and contracting decisions.
  • Guide automation initiatives that improve operational effectiveness.
  • Lead cross-functional teams supporting 340B strategy execution.
  • Present recommendations to executive leadership committees.
  • Influence key stakeholders across Commercial, Finance, Legal, Market Access, Government Pricing, and Compliance.
  • Manage external consultants, auditors, and strategic partners.
  • Develop organizational capabilities related to 340B intelligence and policy evaluation.

Desired Qualifications

  • An MBA, MPH, PharmD, JD, or other advanced degree is preferred.

About the Company

Sandoz

Leader in generic and biosimilar medicines

What does the company do? Sandoz is a global leader in generic and biosimilar medicines, with a broad portfolio of about 1,300 products that address diseases from the common cold to cancer. How does its product work? The medicines are off-patent (generics) or biosimilars that match the reference brands in safety, quality, and efficacy, offering affordable treatment options to patients and helping healthcare systems save money while expanding access. How is it different from competitors? Sandoz emphasizes scale, a long heritage dating back to 1886, and a sizeable global workforce dedicated to broadening patient access, aiming for large social impact and substantial healthcare savings. Its leadership in biosimilars and the breadth of its portfolio set it apart in the market. What is the company's goal? To pioneer access for patients by making high-quality medicines more affordable and widely available worldwide.

Company size
10,001+
Company stage
IPO
Headquarters
Basel, Switzerland
Founded
1886

Recently Posted Jobs

Explore more opportunities at Sandoz

See more jobs